Alumis ALMS
NASDAQ ALMS
$6.81 +0.11 (+1.64%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alumis (ALMS) Total Liabilities (2023 - 2026)

Updated

Alumis' Total Liabilities was $108.46 million in Q2 2026, down 13.6% from $125.6 million a year earlier.

Analysis

Alumis (ALMS) Total Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2025, Total Liabilities at Alumis came in at $110.64 million, up 36.8% from FY2024.

  • In earlier years, Total Liabilities was $80.89 million in FY2024 (-81.1%) and $428.87 million in FY2023.
  • Quarterly Total Liabilities has moved between $64.17 million (Q3 2024) and $703.93 million (Q2 2024) over five years.
  • Compared with a year earlier, Total Liabilities was higher in two of the last five quarters, with an average decline of 15.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 116.09 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 141.05 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 37.53 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 115.64 Bn
10 Alumis 870.27 Mn -804.57 Mn - 108.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.46 Mn
Dec 31, 2025 110.64 Mn
Sep 30, 2025 103.24 Mn
Jun 30, 2025 125.60 Mn
Mar 31, 2025 92.98 Mn
Dec 31, 2024 80.89 Mn
Sep 30, 2024 64.17 Mn
Jun 30, 2024 703.93 Mn
Dec 31, 2023 428.87 Mn
API Access

Alumis Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ALMS&period=max&api_key=YOUR_API_KEY